| Borderline Dravet syndrome: a useful diagnostic category? | |
| | |
MedLine Citation:
|
PMID: 21463273 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The term "borderline" severe myoclonic epilepsy of infancy (SMEIB) has been used to designate patients in whom myoclonic seizures or generalized spike and wave activity are absent. It has also been used loosely to indicate mild forms of the syndrome. It is now acknowledged that the course and outcome of patients with SMEIB are the same as in the core syndrome. The rate of patients exhibiting SCN1A gene mutations is also similar, and it has been observed that the same mutations can cause both typical and "borderline" forms, indicating causal homogeneity. Defining a borderline form of a syndrome would mean setting the criteria of semiology and severity whereby a given phenotype falls within and outside the core syndrome. Such process has never been made for Dravet syndrome and is of course unrealistic in view its polymorphic expression. The eponym Dravet syndrome has been preferred to designate a syndrome spectrum that also embraces SMEIB. Therefore the term "borderline" Dravet syndrome is improper. The definition "mild form" of Dravet syndrome would certainly be more suitable to indicate those patients exhibiting a less severe or incomplete form of the syndrome. Variability in severity favors the concept that SCN1A loss of function causes a spectrum of epilepsy phenotypes in which seizures, often prolonged and precipitated by fever, are the prominent feature and schematic subdivisions would be inappropriate, at least in the early stages. An initial definition of SCN1A gene-related epilepsy would perhaps be more suitable when a mutation of this gene is ascertained and the clinical picture is still ill defined. |
| | |
Authors:
|
Renzo Guerrini; Hirokazu Oguni |
Related Documents
:
|
1258603 - Multiple dermal perifollicular fibromas with polyps of the colon -- report of a peculia... 7065683 - Factitial dermatitis as the presenting sign of multiple lentigines syndrome. therapeuti... 21598233 - Abnormal tc99m sulesomab in klippel-trenaunay syndrome. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Epilepsia Volume: 52 Suppl 2 ISSN: 1528-1167 ISO Abbreviation: Epilepsia Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-04-05 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2983306R Medline TA: Epilepsia Country: United States |
Other Details:
|
Languages: eng Pagination: 10-2 Citation Subset: IM |
Copyright Information:
|
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy. |
Affiliation:
|
Children's Hospital A Meyer and University of Florence, Florence, Italy. r.guerrini@meyer.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The core Dravet syndrome phenotype.
Next Document: Electroencephalographic characteristics of Dravet syndrome.